Hidden Horror Challenges for Oral Mucormycosis with COVID 19 Patients Case Series Original Study

Abstract

Authors: Rawaa Y. Al-Rawee, Ali Mohammad Saeed, Ahmed khaldoon Tariq Alomari, Bashar Abdul-Ghani Tawfeeq, Saud Salim Saeed. Purpose: Explore the early identification significance of mucormycosis in Covid 19 patients and highlighting the role of MDT cooperation in reducing mortality and morbidity rate. Material and Method: Forty-three patients are included in this study as mucormycosis infection with diabetes mellitus (MID) divided in 2 groups: group 1: 15 patients recorded to have mucormycosis infection with diabetesmellitus only (MID), group 2: 28 patients recorded to have previous Covid attack added to mucormycosis infection with diabetes mellitus (CMID). Result: Mann-Whitney Test and Wilcoxon W test are used for detection of significant differences between 2 groups where z value considers less than 0.5 to be significant. Severity and stages confirm high significant difference between MID and CMID (0.042, 0.000) while prognosis confirm no significant differences (0.521). Conclusion: Diabetic patients are more prone to have viral and bacterial infections make them need special care. COVID-19 with the immune dysregulation is concomitant with a significant prevalence of fungal infections as secondary attacks; early diagnosis and management can help in reduce subsequently mortality and morbidity.